Cho, In-So Lim, Jihye Chang, Min-Seok Lee, Ji-Ho
Published in
BMC pulmonary medicine
Previous studies have consistently reported a decrease in hospital admissions for respiratory diseases during the coronavirus disease 2019 (COVID-19) pandemic. However, the impact of the pandemic on idiopathic pulmonary fibrosis (IPF) admissions remains unknown. This study used data from the Korean National Health Insurance Service database. IPF wa...
Wang, Jiaxing Meng, Ran Sun, Zhengzhong Xuan, Lyv Wang, Jiao Gu, Yan Zhang, Yuxiang
Published in
BMC pulmonary medicine
To investigate the role of Parkin overexpression-induecd mitophagy in alleviating acute lung injury of exertional heat stroke(EHS) rats. Eighty SD rats were divided into four groups: Control group (CON group), Control Parkin overexpression group (CON + Parkin group), exertional heat stroke group (EHS group), and exertional heat stroke Parkin overex...
Chen, Yinong Zhang, Shuai Lu, Xin Xie, Wanmu Wang, Chen Zhai, Zhenguo
Published in
BMC pulmonary medicine
Patients with congenital myopathies may experience respiratory involvement, resulting in restrictive ventilatory dysfunction and respiratory failure. Pulmonary hypertension (PH) associated with this condition has never been reported in congenital ryanodine receptor type 1(RYR1)-related myopathy. A 47-year-old woman was admitted with progressively e...
Potentas-Policewicz, Malgorzata Szolkowska, Malgorzata Blasinska, Katarzyna Gawryluk, Dariusz Sobiecka, Malgorzata Fijolek, Justyna
Published in
BMC pulmonary medicine
Granulomatosis with polyangiitis (GPA) is characterized by necrotizing granulomatous inflammation with necrotizing vasculitis predominantly affecting small to medium vessels. The survival rates have drastically improved; however, GPA can be lethal, with older patients having a worse prognosis and higher mortality than younger patients. Moreover, th...
Cui, Shilei Ji, Haiying Li, Li Zhu, Huili Li, Xiangyang Gong, Ying Song, Yuanlin Hu, Lijuan Wu, Xu
Published in
BMC pulmonary medicine
Comparisons between endurance training (ET) and resistance training (RT) have produced equivocal findings in chronic obstructive pulmonary disease (COPD) patients. The purpose of our study is to investigate the effectiveness and long-term outcomes of adding ET and RT to conventional medical treatment in patients with COPD. A secondary objective is ...
Song, Lijun Li, Min Zhang, Tianlong Huang, Lei Ying, Jianjun Ying, Lan
Published in
BMC pulmonary medicine
High-flow nasal cannula (HFNC) has emerged as a promising noninvasive method for delivering oxygen to critically ill patients, particularly those with sepsis and acute lung injury. However, uncertainties persist regarding its therapeutic benefits in this specific patient population. This retrospective study utilized a propensity score-matched cohor...
Cai, Zhe Zuo, Linwei Hu, Fangfang You, Huiyan Lu, Xiangtong Liao, Shousheng Liu, Fanrong Li, Lixiang Huang, Wenyong
Published in
BMC pulmonary medicine
To present an unusual case of abnormal LCA expression and CD43 in SCLC and to review the reported literature to avoid potential diagnostic pitfalls. A 73-year-old male patient suffered from persistent back pain for more than one month. MRI revealed a compression fracture of the L1-L5 vertebra. A CT scan revealed multiple nodules and masses at the l...
Xu, Weixian Chen, Miaozhen Liu, Songtao Su, Yi Zhang, Yunhai
Published in
BMC pulmonary medicine
Iopamidol is a non-ionic, water-soluble iodine contrast agent that is considered safe for intravenous or intra-arterial administration and is widely used both in the general population and in patients undergoing oncological treatment. While adverse reactions to iopamidol have been documented, to date, no pulmonary and gastric hemorrhages induced by...
Wang, Hsin-Yi Tsai, Shih-Chuan Lin, Yi-Ching Hou, Jing-Uei Chao, Chih-Hao
Published in
BMC pulmonary medicine
The coronavirus disease 2019 (COVID-19) pandemic has had a significant impact on global health and economies, resulting in millions of infections and deaths. This retrospective cohort study aimed to investigate the effect of antifibrotic agents (nintedanib and pirfenidone) on 1-year mortality in COVID-19 patients with acute respiratory failure. Dat...
Kayser, Moritz Z Suhling, Hendrik Fuge, Jan Hinze, Christopher A Drick, Nora Kneidinger, Nikolaus Behr, Jürgen Taube, Christian Welte, Tobias Haasler, Ina
...
Published in
BMC pulmonary medicine
Monoclonal antibodies (biologics) drastically changed severe asthma therapy. Mepolizumab (anti-interleukin (IL) 5), benralizumab (anti-IL5 receptor alpha), and dupilumab (anti-IL4/13) are the most used biologics in this context. While all biologics are efficient individually, the choice of biologic is complicated by insufficient data on their compa...
